Literature DB >> 19593951

Effects of ankylosing spondylitis on the heart.

Yilmaz Gunes1, Mustafa Tuncer, Unal Guntekin, Musa Sahin, Levent Yazmalar.   

Abstract

BACKGROUND: Various cardiac pathologies have been linked to ankylosing spondylitis (AS) in various conflicting reports.
OBJECTIVES: A pilot exploration is done to search frequencies of structural heart involvement, arrhythmias and heart rate variability (HRV) in AS patients.
METHODS: Thirty-five AS patients and 25 healthy people were evaluated with 12-lead electrocardiography, echocardiography and 24-hour Holter monitoring.
RESULTS: No patient had significant valvular heart disease except one. Ventricular and supraventricular premature beat counts were significantly higher in AS patients compared to the control group (P = 0.002 and 0.01). Frequency of ventricular premature beats was significantly correlated with isovolumetric relaxation time (IVRT) (r = 0.291 , P = 0.025). Abnormal ECG was defined in 4 AS patients; 2 incomplete right bundle-branch block (RBBB), one left axis deviation and one complete RBBB and left anterior hemiblock. QT and P wave dispersions were not significantly different between AS patients and the control group. Although mitral inflow deceleration time (DT) and IVRT were significantly longer in AS patients (P < 0.001, both), frequency of diastolic dysfunction was not significantly different. Among HRV parameters rMSSD (day time), PNN50 (day time) and SDSD (day and night time) were significantly lower than the control group. There were weak to moderate but significant negative correlations of IVRT and DT with these parameters.
CONCLUSIONS: In this small sample there is no significant increase in structural heart disease in patients with AS. Diastolic functions may be affected in the course of disease and this may be associated with increased frequency of premature beats. Day time heart rate variability is decreased and associated with diastolic function parameters of IVRT and DT in AS patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19593951     DOI: 10.2143/AC.64.3.2038026

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  7 in total

1.  Differences in cardiovascular manifestations between ankylosing spondylitis patients with and without kyphosis.

Authors:  Jun Fu; Manyan Wu; Yan Liang; Kai Song; Ming Ni; Yonggang Zhang; Jiying Chen
Journal:  Clin Rheumatol       Date:  2016-06-07       Impact factor: 2.980

Review 2.  Cardiovascular Morbidity in Ankylosing Spondylitis: A Focus on Inflammatory Cardiac Disease.

Authors:  Pradnya Brijmohan Bhattad; Mugdha Kulkarni; Parasbhai D Patel; Mazen Roumia
Journal:  Cureus       Date:  2022-06-03

3.  Evaluation of cardiac autonomic nervous system in patients with ankylosing spondylitis using 12-lead electrocardiography and Holter monitoring.

Authors:  Mustafa Candemir; Burcu Candemir; Adem Ertürk
Journal:  Clin Rheumatol       Date:  2020-03-25       Impact factor: 2.980

Review 4.  Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights.

Authors:  Michael T Nurmohamed; Irene van der Horst-Bruinsma; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

5.  Echocardiographic and Electrocardiographic Findings in Patients with Ankylosing Spondylitis without Cardiovascular Risk Factors.

Authors:  Simin Almasi; Behzad Farahani; Niloufar Samiei; Yousef Rezaei; Habib Mahmoodi; Mostafa Qorbani
Journal:  J Tehran Heart Cent       Date:  2020-04

6.  Cardiac Autonomic Function in Patients With Ankylosing Spondylitis: A Case-Control Study.

Authors:  Cheng-Yu Wei; Woon-Man Kung; Yi-Sheng Chou; Yao-Chin Wang; Hsu-Chih Tai; James Cheng-Chung Wei
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

7.  Increased risk of valvular heart disease in patients with ankylosing spondylitis: a nationwide population-based longitudinal cohort study.

Authors:  Wun-Zhih Siao; Chin-Hsiu Liu; Yu-Hsun Wang; James Cheng-Chung Wei; Gwo-Ping Jong
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-06-18       Impact factor: 5.346

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.